One Patient, Two Cancers, Multiple Experts Skip to main content Close Select your preferred language English عربى 简体中文 繁體中文 فارسي עִברִית 日本語 한국어 Русский Español Tagalog Menu Close Call 1-800-CEDARS-1 toggle search form Close Los Angeles, 11 February 2022 06:02 AM America/Los_Angeles One Patient Two Cancers Multiple Experts A Path Forward in a Day Maxine Aubry, here with her husband, Robert, left her first pancreatic cancer appointment armed with a treatment plan. Photo by Cedars-Sinai. Patient Maxine Aubry and husband Bob Aubry. Cedars-Sinai Cancer Patient Receives Treatment Plans in Just Hours at Pancreatic Cancer Multidisciplinary Clinic and Precision Medicine Program Maxine Aubry, a paragon of health for most of her 81 years, was shocked by the back-to-back cancer diagnoses she received last summer. “I was devastated,” said Aubry, who lives in the Baldwin Hills neighborhood of Los Angeles. “I had no real warning signs. I had no idea how to face all of that news.” Aubry’s learning curve was quick. She was diagnosed in June with an aggressive cancer in her left breast, which required an urgent mastectomy. Then in July, after experiencing severe digestive distress, a CT scan of her abdomen revealed a suspicious mass on her pancreas. Aubry tried to convince herself that the pancreatic growth was “just a cyst,” she said, but fear of an additional cancer engulfed her. “We were overwhelmed and not sure about where to start,” said Robert Aubry, Maxine Aubry’s husband of 32 years. Her breast oncologist recommended a Cedars-Sinai Cancer program that “made all the difference. Everything was explained to us, with empathy and concern, at one appointment. All of our questions were answered, and we had a plan.” All in a Day The Pancreatic Cancer Multidisciplinary Clinic and Precision Medicine Program, which officially launched in October 2021, involves a single-day visit to the clinic, where patients confer with a multidisciplinary team of pancreatic cancer experts: a surgeon, gastroenterologist, social worker, dietitian, oncologists, and specialists knowledgeable about current cancer treatments and clinical trials. Patients also undergo genetic testing. At the end of the six-hour visit, “patients walk out of the clinic with a single piece of paper containing bullet points with comprehensive treatment recommendations, which they can take to their own surgeons and oncologists,” said Arsen Osipov, MD, a medical oncologist and researcher in the Gastrointestinal Research Group at the Samuel Oschin Cancer Center, and head of the program. “They can return to the clinic every two, four or six months for follow-up, if needed.” Long and Winding Road In a typical scenario, pancreatic cancer patients start with one specialist, who refers them to a second, who refers them to a third, Osipov explained. “It can take four to six weeks to get through the diagnostic process for this complicated cancer,” he added. “We do it in a matter of a few hours. Our goal is to minimize that burden and reduce the anxiety and wear and tear of traveling to multiple clinics. These patients want to begin treatments as soon as possible.” Pancreatic cancer is the fourth leading cause of cancer death, with a five-year survival rate of about 10%. The disease accounts for about 3% of all cancers in the U.S. and about 7% of all cancer deaths, according to the American Cancer Society. Some patients who visit the Cedars-Sinai multidisciplinary clinic already have been diagnosed with cancer and want a second opinion and treatment recommendations. Others seek a diagnostic work-up to rule out or confirm pancreatic cancer. All patients are assigned team members to handle their cases so that surgery and treatments can begin without delay in case cancer is confirmed, said Osipov, an assistant professor of Medicine. “We hope their results are benign,” he said, “but we’re prepared to handle any diagnosis.” Maxine Aubry s Journey Following Maxine Aubry’s August mastectomy for triple negative breast cancer, her medical oncologist, Marina Vaysburd, MD, coordinated a visit with Osipov’s team to evaluate the suspicious growth on her pancreas. Simon Lo, MD, director of the Pancreatic and Biliary Diseases Program, and gastrointestinal lead for the multidisciplinary clinic, performed an endoscopic biopsy in September, which revealed concerning precancerous changes. Surgical lead Nicholas N. Nissen, MD, director of Hepatobiliary and Pancreatic Cancer, performed surgery in October, which confirmed the cancer. Nissen removed a large pancreatic cyst and part of her pancreas, as well as a cyst on her adrenal gland, the Aubrys said. “Her case was complicated,” Osipov explained. “She was dealing with two cancers at the same time, and the pancreatic cancer was aggressive and rare. In addition to diagnosing her condition, we wanted to concentrate on her quality of life as she faced surgery and treatments.” In December, one week after a follow-up visit to the clinic, Maxine Aubry began chemotherapy treatments that address both her breast and pancreatic cancers. She is handling it well, she said, with few side effects. A cancer veteran now, she offers advice for others facing a similar situation. “After my diagnoses, I thought that was ‘it’ was for me, but it wasn’t,” she said. “Find a team that can answer all of your questions, and then get on with it. It doesn’t have to be the end of the world.” https://doi.org/10.1038/s43018-021-00185 Read about pancreatic cancer on the Cedars-Sinai Blog: New Approaches to Pancreatic Cancer Care Related Stories RSS feed - Related Stories (opens in new window) View all headlines - Related Stories Cancer Patient Sails Again A Tumor on Her Spine Kept Jeannea Jordan Ashore but Her Cedars-Sinai Neurosurgeon Got Her Back on Her Boat September 19, 2022 06:00 AM America/Los_Angeles Jeannea Jordan, who turns 80 in October, is a local sailing pioneer who began racing and cruising her 30-foot sailboat 25 years ago when few women were part of the sport. When a tumor on her spine ran her aground last year and her oncologist at … Read more Study Active Surveillance an Effective Option for Thyroid Cancer Research Published in JAMA Oncology Determines Many Low-Risk Thyroid Cancers Can Be as Effectively Managed With Monitoring as With Surgery September 15, 2022 08:01 AM America/Los_Angeles A novel clinical trial from Cedars-Sinai Cancer shows that active surveillance is an effective treatment for many low-risk thyroid cancer patients. The study, published in JAMA Oncology, also showed for the first time that patients who opted for … Read more Study Patients Prefer Stool Test to Colonoscopy Cedars-Sinai Investigators Find Nearly Three-Quarters of Study Participants Prefer Less-Invasive Option for Colorectal Cancer Screening September 12, 2022 10:00 AM America/Los_Angeles Three-quarters of people prefer to do a fecal immunochemical test (FIT) rather than a colonoscopy for their regular colorectal cancer screening, according to a new Cedars-Sinai study.Unlike colonoscopies, FIT doesn’t require lengthy preparation, … Read more Show previous items Show next items Contact the Media Team Email: [email protected] Contact Share this release One Patient Two Cancers Multiple Experts A Path Forward in a Day Share on: Twitter Share on: Facebook Share on: LinkedIn Search Our Newsroom Social media Visit our Facebook page (opens in new window) Follow us on Twitter (opens in new window) Visit our Youtube profile (opens in new window) (opens in new window) Latest news 07 Oct 2022 - HealthDay: Black Women Less Likely to Get Laparoscopic Fibroid Surgeries 07 Oct 2022 - Faculty Publications: Sept. 29-Oct. 6 07 Oct 2022 - Fine-Tuning Organ-Chip Technology 06 Oct 2022 - KCRW: Want New Omicron Booster? Wait at Least 2 Months After Last Shot 05 Oct 2022 - Cedars-Sinai Schedules Free Flu Vaccine Clinics 04 Oct 2022 - Cedars-Sinai Showcases Hispanic and Latinx Art Newsroom Home